Login
Home
Charts
Search
Watchlist
Products

Biopol Chemicals Ltd

BIOPOL·NSE
₹48.65+2.53%Wed, 23 Sept '26 15:31
Industry:Chemicals - Speciality
Indices:

Biopol Chemicals Ltd

BIOPOL
NSE
₹48.65
+2.53%
|Wed, 23 Sept '26 15:31
SOICxStockScans Reports
Industry
Chemicals - Speciality
Indices
View
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹53Cr
Close
Close Price
₹48.95
Industry
Industry
Chemicals - Speciality
PE
Price To Earnings
7.92
PS
Price To Sales
0.65
Revenue
Revenue
₹81Cr
Rev Gr TTM
Revenue Growth TTM
64.86%
PAT Gr TTM
PAT Growth TTM
108.22%

Quarterly Results

Standalone
Numbers
Percentage
QuarterSep 2024Mar 2025Sep 2025Mar 2026
Revenue
RevenueCr
15343249
Growth YoY
Revenue Growth YoY%
106.046.2
Expenses
ExpensesCr
13292740
Operating Profit
Operating ProfitCr
2449
OPM
OPM%
13.113.214.018.3
Other Income
Other IncomeCr
0000
Interest Expense
Interest ExpenseCr
0011
Depreciation
DepreciationCr
0000
PBT
PBTCr
2448
Tax
TaxCr
0112
PAT
PATCr
1336
Growth YoY
PAT Growth YoY%
123.7101.3
NPM
NPM%
8.58.99.312.2
EPS
EPS₹
0.00.00.06.2
QuarterSep 2024Mar 2025Sep 2025Mar 2026
Revenue
RevenueCr
15343249
Growth YoY
Revenue Growth YoY%
106.046.2
Expenses
ExpensesCr
13292740
Operating Profit
Operating ProfitCr
2449
OPM
OPM%
13.113.214.018.3
Other Income
Other IncomeCr
0000
Interest Expense
Interest ExpenseCr
0011
Depreciation
DepreciationCr
0000
PBT
PBTCr
2448
Tax
TaxCr
0112
PAT
PATCr
1336
Growth YoY
PAT Growth YoY%
123.7101.3
NPM
NPM%
8.58.99.312.2
EPS
EPS₹
0.00.00.06.2

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2024Mar 2025Mar 2026
Revenue
RevenueCr
254981
Growth
Revenue Growth%
93.364.8
Expenses
ExpensesCr
214368
Operating Profit
Operating ProfitCr
4613
OPM
OPM%
17.413.216.6
Other Income
Other IncomeCr
000
Interest Expense
Interest ExpenseCr
012
Depreciation
DepreciationCr
000
PBT
PBTCr
4612
Tax
TaxCr
113
PAT
PATCr
349
Growth
PAT Growth%
45.5108.1
NPM
NPM%
11.68.811.1
EPS
EPS₹
3.85.510.8
Financial YearMar 2024Mar 2025Mar 2026
Revenue
RevenueCr
254981
Growth
Revenue Growth%
93.364.8
Expenses
ExpensesCr
214368
Operating Profit
Operating ProfitCr
4613
OPM
OPM%
17.413.216.6
Other Income
Other IncomeCr
000
Interest Expense
Interest ExpenseCr
012
Depreciation
DepreciationCr
000
PBT
PBTCr
4612
Tax
TaxCr
113
PAT
PATCr
349
Growth
PAT Growth%
45.5108.1
NPM
NPM%
11.68.811.1
EPS
EPS₹
3.85.510.8

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
8811
Reserves
ReservesCr
1639
Current Liabilities
Current LiabilitiesCr
81715
Non Current Liabilities
Non Current LiabilitiesCr
015
Total Liabilities
Total LiabilitiesCr
183270
Current Assets
Current AssetsCr
173155
Non Current Assets
Non Current AssetsCr
0015
Total Assets
Total AssetsCr
183270
Financial YearMar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
8811
Reserves
ReservesCr
1639
Current Liabilities
Current LiabilitiesCr
81715
Non Current Liabilities
Non Current LiabilitiesCr
015
Total Liabilities
Total LiabilitiesCr
183270
Current Assets
Current AssetsCr
173155
Non Current Assets
Non Current AssetsCr
0015
Total Assets
Total AssetsCr
183270

Cash Flow

Standalone
Financial YearMar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-6-2-13
Investing Cash Flow
Investing Cash FlowCr
-10-15
Financing Cash Flow
Financing Cash FlowCr
7427
Net Cash Flow
Net Cash FlowCr
01-1
Free Cash Flow
Free Cash FlowCr
-6-2-27
CFO To PAT
CFO To PAT%
-217.4-56.0-142.3
CFO To EBITDA
CFO To EBITDA%
-145.5-37.3-94.9
Financial YearMar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-6-2-13
Investing Cash Flow
Investing Cash FlowCr
-10-15
Financing Cash Flow
Financing Cash FlowCr
7427
Net Cash Flow
Net Cash FlowCr
01-1
Free Cash Flow
Free Cash FlowCr
-6-2-27
CFO To PAT
CFO To PAT%
-217.4-56.0-142.3
CFO To EBITDA
CFO To EBITDA%
-145.5-37.3-94.9

Ratios

Standalone
Financial YearMar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
10553
Price To Earnings
Price To Earnings
11.77.9
Price To Sales
Price To Sales
1.30.7
Price To Book
Price To Book
2.11.1
EV To EBITDA
EV To EBITDA
8.4
Profitability Ratios
Profitability Ratios
GPM
GPM%
25.117.021.321.3
OPM
OPM%
17.413.216.616.6
NPM
NPM%
11.68.811.111.1
ROCE
ROCE%
34.030.023.323.3
ROE
ROE%
32.231.718.018.0
ROA
ROA%
16.913.612.912.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
10553
Price To Earnings
Price To Earnings
11.77.9
Price To Sales
Price To Sales
1.30.7
Price To Book
Price To Book
2.11.1
EV To EBITDA
EV To EBITDA
8.4
Profitability Ratios
Profitability Ratios
GPM
GPM%
25.117.021.321.3
OPM
OPM%
17.413.216.616.6
NPM
NPM%
11.68.811.111.1
ROCE
ROCE%
34.030.023.323.3
ROE
ROE%
32.231.718.018.0
ROA
ROA%
16.913.612.912.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Biopol Chemicals Ltd

  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/huwa7zxbhr6mbh4jo702qsrf.pdf

Simplify stock analysis with powerful tools and clear insights for confident, data-driven decisions.

support@stockscans.in
© StockScans by SOIC Technologies Pvt Ltd
349 A, Lodhi Road, Punjabi Bazar, New DelhiData provided by CMOTS Internet Technologies